Fuan Pharmaceutical (Group) Co., Ltd. (SHE:300194)

SHE:300194 Revenue

Fuan Pharmaceutical (Group) had revenue of 385.30M CNY in the quarter ending September 30, 2026, a decrease of -2.42%. This brings the company's total for the last twelve months to 1.65B, down -3.74% year-over-year. In the year 2025, Fuan Pharmaceutical (Group) had annual revenue of 1.74B, down -27.31%. That makes Fuan Pharmaceutical (Group) the 15,941st largest company in the world by revenue and 2,886th in China.

• Revenue (ttm): 1.65B
• Revenue Growth: -3.74%
• P/S Ratio: 2.59
• Revenue / Employee: 551.38K
• Employees: 2,988
• Market Cap: 4.20B

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• East China 655.96M 37.7%
• Central China 348.56M 20.1%
• Southwest Region 227.73M 13.1%
• Northern china 157.75M 9.1%
• Southern China 130.63M 7.5%
• Export and Others 77.04M 4.4%
• Unallocated 60.17M 3.5%
• Other 80.45M 4.6%

Fiscal year ended Dec 31, 2025 See the full SHE:300194 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.74B	-653.18M	-27.31%
Dec 31, 2024	2.39B	-256.28M	-9.68%
Dec 31, 2023	2.65B	226.01M	9.33%
Jan 1, 2023	2.42B	-31.40M	-1.28%
Jan 1, 2022	2.45B	84.80M	3.58%

Data Source: S&P Global Market Intelligence Last updated: Oct 26, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 13, 2026

Data Sources Report a data error